ArticleCell reports2026

Mutant KRAS-driven selective mRNA translation reveals mechanisms and therapeutic vulnerabilities in cancer.

Ankita Shrivastava et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.